Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

This company has been marked as potentially delisted and may not be actively trading.

Surmodics (SRDX) News Today

Surmodics logo

SRDX Latest News

SurModics Completes Merger, Ends Credit Agreement
SurModics Merger with GTCR LLC Clears Legal Hurdle
What's Next: Surmodics's Earnings Preview
Surmodics (SRDX) Q3 EPS Turns Positive
A Look at Surmodics's Upcoming Earnings Report
Surmodics publishes TRANSCEND trial data
Barrington Sticks to Their Hold Rating for SurModics (SRDX)
SurModics (SRDX) Gets a Hold from Barrington
Lake Street Upgrades Surmodics (SRDX)
FTC sues to block acquisition of Surmodics
Surmodics upgraded to Buy from Hold at Lake Street
Surmodics announces clinical use of Pounce XL Thrombectomy System
SurModics (SRDX) Receives a Hold from Lake Street
Hold Rating on SurModics Amid Revenue Shortfall and Acquisition Uncertainty
Surmodics reports Q1 EPS (4c), consensus (12c)
Get Surmodics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SRDX Media Mentions By Week

SRDX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SRDX
News Sentiment

0.00

0.35

Average
Medical
News Sentiment

SRDX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SRDX Articles
This Week

0

1

SRDX Articles
Average Week

Get the Latest News and Ratings for SRDX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Surmodics and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:SRDX) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners